Advances in the clinical development of antiepileptic drugs

R. J. Porter, B. J. Hessie, James Cereghino, G. D. Gladding, H. J. Kupferberg, B. Scoville, B. G. White

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

In this paper we describe advances in the clinical development of antiepileptic drugs as a function of the Antiepileptic Drug Development Program of the National Institute of Neurological and Communicative Disorders and Stroke. This program encompasses both the preclinical and clinical elements of drug development through the Anticonvulsant Screening Project, the Toxicology Project, and the support of controlled clinical trials of potential new drugs that emerge from these projects and promise to be more effective and less toxic than those currently available for the treatment of epilepsy.

Original languageEnglish (US)
Pages (from-to)2645-2649
Number of pages5
JournalFederation Proceedings
Volume44
Issue number10
StatePublished - 1985
Externally publishedYes

Fingerprint

Anticonvulsants
National Institute of Neurological Disorders and Stroke
Communication Disorders
Poisons
Controlled Clinical Trials
Pharmaceutical Preparations
Toxicology
Epilepsy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Porter, R. J., Hessie, B. J., Cereghino, J., Gladding, G. D., Kupferberg, H. J., Scoville, B., & White, B. G. (1985). Advances in the clinical development of antiepileptic drugs. Federation Proceedings, 44(10), 2645-2649.

Advances in the clinical development of antiepileptic drugs. / Porter, R. J.; Hessie, B. J.; Cereghino, James; Gladding, G. D.; Kupferberg, H. J.; Scoville, B.; White, B. G.

In: Federation Proceedings, Vol. 44, No. 10, 1985, p. 2645-2649.

Research output: Contribution to journalArticle

Porter, RJ, Hessie, BJ, Cereghino, J, Gladding, GD, Kupferberg, HJ, Scoville, B & White, BG 1985, 'Advances in the clinical development of antiepileptic drugs', Federation Proceedings, vol. 44, no. 10, pp. 2645-2649.
Porter RJ, Hessie BJ, Cereghino J, Gladding GD, Kupferberg HJ, Scoville B et al. Advances in the clinical development of antiepileptic drugs. Federation Proceedings. 1985;44(10):2645-2649.
Porter, R. J. ; Hessie, B. J. ; Cereghino, James ; Gladding, G. D. ; Kupferberg, H. J. ; Scoville, B. ; White, B. G. / Advances in the clinical development of antiepileptic drugs. In: Federation Proceedings. 1985 ; Vol. 44, No. 10. pp. 2645-2649.
@article{733e1782b9434642b8febcb55cd53371,
title = "Advances in the clinical development of antiepileptic drugs",
abstract = "In this paper we describe advances in the clinical development of antiepileptic drugs as a function of the Antiepileptic Drug Development Program of the National Institute of Neurological and Communicative Disorders and Stroke. This program encompasses both the preclinical and clinical elements of drug development through the Anticonvulsant Screening Project, the Toxicology Project, and the support of controlled clinical trials of potential new drugs that emerge from these projects and promise to be more effective and less toxic than those currently available for the treatment of epilepsy.",
author = "Porter, {R. J.} and Hessie, {B. J.} and James Cereghino and Gladding, {G. D.} and Kupferberg, {H. J.} and B. Scoville and White, {B. G.}",
year = "1985",
language = "English (US)",
volume = "44",
pages = "2645--2649",
journal = "Federation Proceedings",
issn = "0014-9446",
number = "10",

}

TY - JOUR

T1 - Advances in the clinical development of antiepileptic drugs

AU - Porter, R. J.

AU - Hessie, B. J.

AU - Cereghino, James

AU - Gladding, G. D.

AU - Kupferberg, H. J.

AU - Scoville, B.

AU - White, B. G.

PY - 1985

Y1 - 1985

N2 - In this paper we describe advances in the clinical development of antiepileptic drugs as a function of the Antiepileptic Drug Development Program of the National Institute of Neurological and Communicative Disorders and Stroke. This program encompasses both the preclinical and clinical elements of drug development through the Anticonvulsant Screening Project, the Toxicology Project, and the support of controlled clinical trials of potential new drugs that emerge from these projects and promise to be more effective and less toxic than those currently available for the treatment of epilepsy.

AB - In this paper we describe advances in the clinical development of antiepileptic drugs as a function of the Antiepileptic Drug Development Program of the National Institute of Neurological and Communicative Disorders and Stroke. This program encompasses both the preclinical and clinical elements of drug development through the Anticonvulsant Screening Project, the Toxicology Project, and the support of controlled clinical trials of potential new drugs that emerge from these projects and promise to be more effective and less toxic than those currently available for the treatment of epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=0021839165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021839165&partnerID=8YFLogxK

M3 - Article

C2 - 3891417

AN - SCOPUS:0021839165

VL - 44

SP - 2645

EP - 2649

JO - Federation Proceedings

JF - Federation Proceedings

SN - 0014-9446

IS - 10

ER -